Summary:
A multicenter, randomized, double-blind, parallel group, placebo-controlled, phase iib efficacy and safety study of adjunctive azd6765 in patients with Major Depressive Disorder (MDD) and a history of inadequate response to antidepressants.
Qualified Participants Must:
• Be between 18 and 70 years of age
•
Have a clinical diagnosis of major depressive disorder with a lifetime history of inadequate response to at least 3 antidepressants
Qualified Participants May Receive:
Study visits and all study related procedures available at no cost. In addition, possible compensation for each completed visit.